AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01028-07v1
52/3/915    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Perilli, M.
Right arrow Articles by Amicosante, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perilli, M.
Right arrow Articles by Amicosante, G.
Antimicrobial Agents and Chemotherapy, March 2008, p. 915-919, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01028-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

E240V Substitution Increases Catalytic Efficiency toward Ceftazidime in a New Natural TEM-Type Extended-Spectrum β-Lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens Clinical Isolates{triangledown}

Mariagrazia Perilli,1 Giuseppe Celenza,1 Francesca De Santis,1 Cristina Pellegrini,1 Chiara Forcella,1 Gian Maria Rossolini,2 Stefania Stefani,3 and Gianfranco Amicosante1*

Department of Sciences and Biomedical Technologies, University of L'Aquila, L'Aquila,1 Department of Molecular Biology, University of Siena, Siena,2 Laboratory of Microbiology, University of Catania, Catania, Italy3

Received 6 August 2007/ Returned for modification 8 October 2007/ Accepted 14 December 2007

The aim of this study was to characterize a novel extended-spectrum β-lactamase that belongs to the TEM family, the TEM-149 enzyme, and that was isolated from the urine of two hospitalized patients from different hospitals in southern Italy. The peculiarity of this enzyme was the finding of a valine residue at position 240. The array of amino acid substitutions found in TEM-149 was as follows: E104K, R164S, M182T, and E240V. A reversion of a threonine residue at position 182 was also performed to create a new mutant, TEM-149T182M, in order to assess the contribution of this substitution on the kinetic profile and the stability of TEM-149. The blaTEM-149 and blaTEM-149/T182M genes were cloned into pBC-SK, and the corresponding enzymes were purified from recombinant Escherichia coli HB101 by the same procedure. Both enzymes hydrolyzed all β-lactams tested, with a preference for ceftazidime, which was found to be the best substrate. By comparison of the kinetic parameters of the TEM-149 and the TEM-149T182M enzymes, a reduction of the catalytic efficiency for the TEM-149T182M mutant was observed against all substrates tested except benzylpenicillin, cefotaxime, and aztreonam. Tazobactam, clavulanic acid, and sulbactam were good inhibitors of the TEM-149 β-lactamase.


* Corresponding author. Mailing address: Department of Biomedical Sciences and Technologies, University of L'Aquila, Clinical Biochemistry and Molecular Biology, Loc. Coppito, I-67100 L'Aquila, Italy. Phone: 39 0862 433455. Fax: 39 0862 433433. E-mail: amicosante{at}cc.univaq.it

{triangledown} Published ahead of print on 26 December 2007.


Antimicrobial Agents and Chemotherapy, March 2008, p. 915-919, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01028-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.